Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Insider North Carolina.
Press releases published on May 5, 2025

Castle Biosciences Reports First Quarter 2025 Results
Q1 2025 revenue increased 21% over Q1 2024 to $88 million Q1 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, DecisionDx®-SCC, TissueCypher®) increased 33% over Q1 2024 Raising full-year 2025 revenue guidance to $287-297 million …

Context Therapeutics Announces Chief Medical Officer Transition
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …

James River Announces Excess and Surplus Lines Leadership Retirement and Succession Plan
PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) announced today its plans for Todd Sutherland, current Senior Vice President, Management Liability within the Company’s …

Mission Produce® Appoints Michael Sims to Board of Directors
OXNARD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today …

ThredUp Announces First Quarter 2025 Results
All results reported are for continuing operations, unless otherwise noted. Record quarterly revenue of $71.3 million, representing an increase of 10% year-over-year Quarterly gross margin of 79.1% and an increase in gross profit of 9% year-over-year …

James River Announces First Quarter 2025 Results
PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported net income from continuing operations available to common shareholders of $9.0 million ($0.18 per diluted share) …

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …

Adeia Announces First Quarter 2025 Financial Results
Signed 10 deals in the first quarter, highlighted by 4 with new customers Paid down $17 million of debt and repurchased $10 million of common stock Generated $57 million in cash from operations SAN JOSE, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Adeia Inc …

Castle Biosciences to Acquire Previse
Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development FRIENDSWOOD, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- …

TPI Composites, Inc. Announces Date Change for its First Quarter 2025 Earnings Release Date and Conference Call
SCOTTSDALE, Ariz., May 05, 2025 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (“TPI”) (Nasdaq: TPIC) today announced that the company has rescheduled the date of its first quarter 2025 results. The Company will now issue their earnings results after the market …

TTM Technologies, Inc. Announces Upcoming Conference Participation
SANTA ANA, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), today announced that members of its management team will attend the following investor conferences: Barclays Leveraged Conference on May 20th at the Omni Barton …

GigaCloud Technology Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 12, 2025
EL MONTE, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc. (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that it will report …

ServiceTitan to Announce Fiscal First Quarter 2026 Financial Results on June 5, 2025
LOS ANGELES, May 05, 2025 (GLOBE NEWSWIRE) -- ServiceTitan, Inc. (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will report its financial results for the fiscal first quarter ended April 30, 2025 after market close on …

ACV to Participate in Upcoming Investor Conferences
BUFFALO, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the following …

Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …

FibroGen to Report First Quarter 2025 Financial Results
SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2025 financial results on Monday, May 12 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time …

EverQuote Announces First Quarter 2025 Financial Results
First Quarter Revenue Growth of 83% Year-Over-Year to $166.6 million First Quarter Variable Marketing Dollars Increase of 52% Year-Over-Year to $46.9 million Delivers First Quarter Net Income of $8.0 million and Record Adjusted EBITDA of $22.5 million …

The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that the Company will participate in the Goldman Sachs …

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights
Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes patients and patients that are currently uncontrolled on a …

Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …